Among FH patients, 85–90% exhibit mutations in LDLR, 2–4% in PCSK9, 1–12% in apoB, and only a few in LDLRAP1 genes [11,12,13,14]. This evidence concerns the gene LDLRAP1 and familial hyperaldosteronism.